These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 28979999)

  • 1. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
    Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
    Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
    Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
    Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
    Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Role of
    Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX
    Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective and antioxidant effects of PPARα in the ischemic retina.
    Moran E; Ding L; Wang Z; Cheng R; Chen Q; Moore R; Takahashi Y; Ma JX
    Invest Ophthalmol Vis Sci; 2014 May; 55(7):4568-76. PubMed ID: 24825105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
    Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway.
    Wang Z; Moran E; Ding L; Cheng R; Xu X; Ma JX
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3820-32. PubMed ID: 24845641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
    Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction.
    Hu Y; Chen Y; Ding L; He X; Takahashi Y; Gao Y; Shen W; Cheng R; Chen Q; Qi X; Boulton ME; Ma JX
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15401-6. PubMed ID: 24003152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
    Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
    You JJ; Yang CH; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
    Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
    Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
    Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
    Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.
    Zhang B; Hu Y; Ma JX
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3943-52. PubMed ID: 19324842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.
    Wang Y; Lin W; Ju J
    Cell Cycle; 2020 Jun; 19(11):1314-1325. PubMed ID: 32292119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
    Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.